CD - Genomics - The Genomics Services Company
Quote Request
* Email:
* Services & Products of Interest:
Services / Projects Description:
* Verification Code:

Please input "genomics" as verification code.
Contact us to order
45-1 Ramsey Road, Shirley,
NY 11967, USA
Tel: 1-631-372-1052
Fax: 1-631-614-7828
Email:

Europe
Tel: 44-207-048-3343

Circulating Tumor DNA Sequencing


Circulating Tumor DNA Sequencing

CD Genomics provides accurate Circulating Tumor DNA Sequencing services using next-generation sequencing (NGS) technology.


Cell-free, circulating tumor DNA (ctDNA) can act as a noninvasive cancer biomarker, offering a potential alternative to invasive tissue biopsies. Today, researchers are investigating the use of ctDNA as a biomarker for detecting the presence of tumors in various cancer types. In the future, ctDNA could potentially serve as a noninvasive approach for real-time monitoring of treatment response and identifying candidates for therapy.


Next-generation sequencing (NGS) offers the sensitivity and specificity needed to detect low levels of ctDNA in the bloodstream. In addition to targeting a single gene or a subset of genes, NGS can also identify genome-wide tumor-derived alterations in ctDNA.


High-Quality Service:

CD Genomics provides high- and low-throughput ctDNA sequencing services. Using state-of-the-art reagents, software and facilities, we provide a full suite of ctDNA sequencing services with the highest level of quality assurance. Our ctDNA sequencing service using the next-generation sequencing technology provides tests that are more robust, accurate and reliable in resolving allele-level differences in ctDNA of blood.


High-Throughput Service:

   Features:

 • Very low input DNA requirement
 • Sequencing compatibility with short DNA fragments
 • Comprehensive assay: One assay provides high-resolution sequencing, replacing multiple assays
GenSeq Comprehensive TP53 Panel
GenSeq Comprehensive Oncology Panel
 • Unambiguous results: Deeper sequencing with amplicons and paired-end reads enables phasing of TP53 or more oncology-related genes for more accurate, high-resolution typing.
 • Sample-to-report solution: Complete workflow includes ctDNA separation, library prep, sequencing, data analysis, and reporting

Deliverable:
 • Raw data as FASTQ files via hard drive
 • Mutation discovery report


The service is offered for Research use only. Not for use in diagnostic procedures.


cd genomics logo

facebook linkedin twitter google+
CONTACT CD GENOMICS
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-372-1052
Fax: 1-631-614-7828
Email:

Europe
Tel: 44-207-048-3343

SERVICES
Sequencing
Microarray
Genotyping
Aptamers
Custom Libraries
Technology Platforms
Products

Enter your email here to subscribe
Join 10 other subscribers

Terms & Conditions Privacy Policy Sitemap Feedback  Copyright © 2009 - CD Genomics. All rights reserved.